Germline MBD4 deficiency causes a multi-tumor predisposition syndrome.

Loading...
Thumbnail Image

Embargo End Date

Authors

Palles, C
West, HD
Chew, E
Galavotti, S
Flensburg, C
Grolleman, JE
Jansen, EAM
Curley, H
Chegwidden, L
Arbe-Barnes, EH
Lander, N
Truscott, R
Pagan, J
Bajel, A
Sherwood, K
Martin, L
Thomas, H
Georgiou, D
Fostira, F
Goldberg, Y
Adams, DJ
van der Biezen, SAM
Christie, M
Clendenning, M
Thomas, LE
Deltas, C
Dimovski, AJ
Dymerska, D
Lubinski, J
Mahmood, K
van der Post, RS
Sanders, M
Weitz, J
Taylor, JC
Turnbull, C
Vreede, L
van Wezel, T
Whalley, C
Arnedo-Pac, C
Caravagna, G
Cross, W
Chubb, D
Frangou, A
Gruber, AJ
Kinnersley, B
Noyvert, B
Church, D
Graham, T
Houlston, R
Lopez-Bigas, N
Sottoriva, A
Wedge, D
Genomics England Research Consortium,
CORGI Consortium,
WGS500 Consortium,
Jenkins, MA
Kuiper, RP
Roberts, AW
Cheadle, JP
Ligtenberg, MJL
Hoogerbrugge, N
Koelzer, VH
Rivas, AD
Winship, IM
Ponte, CR
Buchanan, DD
Power, DG
Green, A
Tomlinson, IPM
Sampson, JR
Majewski, IJ
de Voer, RM

Document Type

Journal Article

Date

2022-05-05

Date Accepted

2022-03-30

Abstract

We report an autosomal recessive, multi-organ tumor predisposition syndrome, caused by bi-allelic loss-of-function germline variants in the base excision repair (BER) gene MBD4. We identified five individuals with bi-allelic MBD4 variants within four families and these individuals had a personal and/or family history of adenomatous colorectal polyposis, acute myeloid leukemia, and uveal melanoma. MBD4 encodes a glycosylase involved in repair of G:T mismatches resulting from deamination of 5'-methylcytosine. The colorectal adenomas from MBD4-deficient individuals showed a mutator phenotype attributable to mutational signature SBS1, consistent with the function of MBD4. MBD4-deficient polyps harbored somatic mutations in similar driver genes to sporadic colorectal tumors, although AMER1 mutations were more common and KRAS mutations less frequent. Our findings expand the role of BER deficiencies in tumor predisposition. Inclusion of MBD4 in genetic testing for polyposis and multi-tumor phenotypes is warranted to improve disease management.

Citation

American Journal of Human Genetics, 2022, 109 (5), pp. 953 - 960

Source Title

American Journal of Human Genetics

Publisher

CELL PRESS

ISSN

0002-9297

eISSN

1537-6605
1537-6605

Research Team

Cancer Genomics
Evol Genomics & Modelling

Notes